In March 2025, the company declared new strategies for the immediate-to-shopper offering of its Wegovy weight loss drug. The company recognized a fresh pharmacy, termed NovoCare, which might demand clients $499 every month for usage of the drug, less than half the price of the drug via other pharmaceutical distribution networks.[fifty three]Integra